Are we reading too much into the term 'customer base'. It might have just been an odd way to describe the first customer. It could simply be a reference to the many tests that a clinical trial will run through ICON. It could be multiple clinical trials from one customer. It was good to hear they are 'talking to many pharma's'. If you recall, last year AMBS had over 50 1:1 meetings at BIO.